PT-141 represents a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound operates by enhancing specific receptors throughout the body, causing to improved sexual function. Preclinical studies have suggested that PT-141 has the potential to remarkably address a spectrum of sexu